Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages
Tuberculosis (TB) is still a devastating disease and more people have died of TB than any other infectious diseases throughout the history. The current therapy consists of a multidrug combination in a long-term treatment, being associated with the appearance of several adverse effects. Thus, solid l...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , , , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2018
|
| Texto completo: | https://hdl.handle.net/10216/126510 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/126510 |